CO4810225A1 - Comprimido de mesilato de trovafloxacino - Google Patents

Comprimido de mesilato de trovafloxacino

Info

Publication number
CO4810225A1
CO4810225A1 CO99003190A CO99003190A CO4810225A1 CO 4810225 A1 CO4810225 A1 CO 4810225A1 CO 99003190 A CO99003190 A CO 99003190A CO 99003190 A CO99003190 A CO 99003190A CO 4810225 A1 CO4810225 A1 CO 4810225A1
Authority
CO
Colombia
Prior art keywords
trovafloxacino
mesylate tablet
diluent
compositions
mesylate
Prior art date
Application number
CO99003190A
Other languages
English (en)
Inventor
Dale Johnson Alton
Christopher Michael Sinko
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CO4810225A1 publication Critical patent/CO4810225A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones, especialmente en forma de comprimidos, que contienen la forma polimorfo I del mesilato de trovafloxacino, un lubricante, y celulosa microcristalina (MC) como diluyente. Tales composiciones que emplean MC como diluyente presentan buenas propiedades de estabilidad durante el almacenamiento y de disolución.
CO99003190A 1998-01-21 1999-01-21 Comprimido de mesilato de trovafloxacino CO4810225A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
CO4810225A1 true CO4810225A1 (es) 1999-06-30

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99003190A CO4810225A1 (es) 1998-01-21 1999-01-21 Comprimido de mesilato de trovafloxacino

Country Status (34)

Country Link
US (1) US6187341B1 (es)
EP (1) EP0930068A3 (es)
JP (1) JPH11269072A (es)
KR (1) KR100314977B1 (es)
CN (1) CN1227743A (es)
AP (1) AP1094A (es)
AR (1) AR012780A1 (es)
AU (1) AU758381B2 (es)
BG (1) BG103106A (es)
BR (1) BR9900116A (es)
CA (1) CA2259698C (es)
CO (1) CO4810225A1 (es)
DZ (1) DZ2712A1 (es)
EA (1) EA003247B1 (es)
GT (1) GT199900004A (es)
HR (1) HRP990023A2 (es)
HU (1) HUP9900154A3 (es)
ID (1) ID23735A (es)
IL (1) IL128051A0 (es)
IS (1) IS4947A (es)
MA (1) MA24747A1 (es)
NO (1) NO990243L (es)
NZ (1) NZ333838A (es)
OA (1) OA10958A (es)
PA (1) PA8466701A1 (es)
PE (1) PE20000169A1 (es)
PL (1) PL330981A1 (es)
SG (1) SG70666A1 (es)
SK (1) SK4299A3 (es)
TN (1) TNSN99007A1 (es)
TR (1) TR199900089A3 (es)
TW (1) TW518224B (es)
YU (1) YU2399A (es)
ZA (1) ZA99393B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU229065B1 (en) * 1998-11-10 2013-07-29 Bayer Ip Gmbh Pharmaceutical moxifloxacin compositions
CA2382834A1 (en) * 1999-09-20 2001-03-29 Alza Corporation Process for lessening polymorphic conversion of a drug
JP4803935B2 (ja) * 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Ｆａｂｉ阻害剤
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
ATE420640T1 (de) * 2001-04-06 2009-01-15 Affinium Pharm Inc Fab-i-inhibitoren
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
US7790709B2 (en) * 2002-12-06 2010-09-07 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
CA2519429C (en) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
ATE382338T1 (de) * 2003-03-19 2008-01-15 Jordanian Pharmaceutical Mfg Nicht-hygroskopische pharmazeutische zusammensetzungen die nicht hydratisierte quinolon-carbonsäure enthalten
US8906413B2 (en) 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
CA2531637A1 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
DK1828167T3 (da) 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
WO2006044805A2 (en) * 2004-10-15 2006-04-27 Supernus Pharmaceuticals, Inc. Less abusable pharmaceutical preparations
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
PT3419628T (pt) 2016-02-26 2021-01-05 Debiopharm Int Sa Medicamento para o tratamento de infeções do pé diabético

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
WO1997007800A1 (en) * 1995-08-29 1997-03-06 Pfizer Inc. Zwitterionic forms of trovafloxacin

Also Published As

Publication number Publication date
TNSN99007A1 (fr) 2005-11-10
BG103106A (en) 1999-08-31
TW518224B (en) 2003-01-21
NO990243L (no) 1999-07-22
NZ333838A (en) 2000-03-27
AP9901443A0 (en) 1999-03-31
JPH11269072A (ja) 1999-10-05
NO990243D0 (no) 1999-01-20
IS4947A (is) 1999-07-22
BR9900116A (pt) 2000-05-02
EP0930068A2 (en) 1999-07-21
EA199900046A3 (ru) 1999-12-29
KR19990068014A (ko) 1999-08-25
MA24747A1 (fr) 1999-10-01
AR012780A1 (es) 2000-11-08
DZ2712A1 (fr) 2003-09-01
PE20000169A1 (es) 2000-03-10
HRP990023A2 (en) 1999-08-31
CN1227743A (zh) 1999-09-08
HUP9900154A2 (hu) 1999-09-28
HU9900154D0 (en) 1999-03-29
HUP9900154A3 (en) 2000-12-28
EP0930068A3 (en) 1999-12-22
AP1094A (en) 2002-08-19
TR199900089A2 (xx) 1999-10-21
EA199900046A2 (ru) 1999-08-26
ID23735A (id) 2000-05-11
CA2259698A1 (en) 1999-07-21
PL330981A1 (en) 1999-08-02
YU2399A (sh) 2002-06-19
PA8466701A1 (es) 2000-09-29
KR100314977B1 (ko) 2001-11-24
EA003247B1 (ru) 2003-02-27
IL128051A0 (en) 1999-11-30
AU758381B2 (en) 2003-03-20
AU1217399A (en) 1999-08-12
OA10958A (en) 2001-10-31
CA2259698C (en) 2003-04-15
SK4299A3 (en) 2000-06-12
SG70666A1 (en) 2000-02-22
US6187341B1 (en) 2001-02-13
GT199900004A (es) 2000-07-08
TR199900089A3 (tr) 1999-10-21
ZA99393B (en) 2000-07-21

Similar Documents

Publication Publication Date Title
CO4810225A1 (es) Comprimido de mesilato de trovafloxacino
SE0202463D0 (sv) Novel compounds
BRPI0514474A (pt) multiparticulados
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
AR054782A2 (es) Composiciones farmaceuticas y tabletas que contienen irbesartan en combinacion con un diuretico
NO20051259L (no) Biaryl-diazabicykloalkanamider som nikotinacetylcholinagonister
AU1192302A (en) Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
ES2125377T3 (es) Azaheterociclicos triciclicos n-acilatados utiles como antagonistas de vasopresina.
RS50209B (sr) Derivati pirazolokarboksilne kiseline, njihova priprema, farmaceutske kompozicije sa sadržajem istih
BR0109943A (pt) Composições farmacêuticas
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
GR3034996T3 (en) Aqueous detergent compositions containing chelants which remain undissolved under acidic conditions
AR036658A1 (es) Formulacion de dosificacion oral de fundicion instantanea
MY137156A (en) Dual nk1/nk3 derivatives
YU39803A (sh) Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
MY133322A (en) Storage stable tablets of fosinopril sodium
RU2009106483A (ru) Огнезащитный состав
ECSP992822A (es) Comprimido de mesilato de trovafloxacina
PE13395A1 (es) Composicion farmaceutica de imidazolil carbazolona
DK1244614T3 (da) Tryptase-inhibitorer
IS7107A (is) Samsett borð
YU26001A (sh) Derivati ureidopiperidina kao selektivni antagonisti ljudskih nk3 receptora
DK1140810T3 (da) Benzensulfonamidderivater samt deres anvendelse
AU2001218083A1 (en) Ace inhibitor-vasopressin antagonist combinations
PA8517201A1 (es) Composiciones farmaceuticas antihistaminicas anticongestivas liquidas estables